Horiba for Healthcare

15/10/2026

In Chase the Case #61, explore the case of a 22-year-old patient with severe allergic asthma and marked peripheral eosinophilia.
See how the Yumizen H500 generated eosinophilia and immature cell flags, prompting a peripheral smear review and supporting further investigation of this interesting hematology case.

✅ View the case on the website: https://eu1.hubs.ly/H0z3z9L0
✅ Subscribe: https://eu1.hubs.ly/H0z3zbk0

Explore a clinical case of severe allergic asthma with marked reactive eosinophilia and discover how the Yumizen H500 supports hematology analysis.

14/10/2026

Complete Blood Count (CBC) remains one of the most frequently ordered laboratory tests, yet valuable inflammatory biomarkers such as the Neutrophil-to-Lymphocyte Ratio (NLR) and Granulocyte-to-Lymphocyte Ratio (GLR) are often underutilized.

This workshop will explore the biological significance of these hematological ratios and how, when combined with C-reactive Protein (CRP), they can provide additional insights into immune response, inflammation, and disease severity.

Participants will discover how these biomarkers can support clinical decision-making, risk stratification, and the management of infectious and inflammatory conditions. The workshop will also examine the role of NLR, GLR, and CRP in disease severity assessment and explore how factors such as age and comorbidities can influence biomarker interpretation.

🔗Sign up here: https://eu1.hubs.ly/H0z3t4L0

13/10/2026

World Thrombosis Day 2026 highlights the importance of women's health across the lifespan and the need for greater awareness of thrombosis risk.
Among the conditions that deserve attention is Antiphospholipid Syndrome (APS), an autoimmune disorder associated with thrombosis and adverse pregnancy outcomes. Accurate laboratory investigation, including lupus anticoagulant testing, plays a key role in supporting diagnosis and patient management.
🔗In our latest article, discover why quality starts before the analysis and explore key considerations for confident APS assessment: https://eu1.hubs.ly/H0y_QdQ0

09/10/2026

Veterinary hematology is where the workflow begins.​​
The Yumivet VH2500 supports veterinary laboratories with fast, detailed hematology results and a workflow designed for demanding daily activity.​
​
Designed for multi-species hematology testing, the Yumivet VH2500 combines a throughput of up to 120 samples per hour, continuous sample loading, STAT access, and 57 reportable parameters to deliver fast and reliable hematology insights for veterinary laboratories.​
​
👉 Explore Yumivet VH2500 and contact our team: https://eu1.hubs.ly/H0yYRsp0

08/10/2026

Complete Blood Count (CBC) remains one of the most frequently ordered laboratory tests, yet valuable inflammatory biomarkers such as the Neutrophil-to-Lymphocyte Ratio (NLR) and Granulocyte-to-Lymphocyte Ratio (GLR) are often underutilized.

This workshop will explore the biological significance of these hematological ratios and how, when combined with C-reactive Protein (CRP), they can provide additional insights into immune response, inflammation, and disease severity.

Participants will discover how these biomarkers can support clinical decision-making, risk stratification, and the management of infectious and inflammatory conditions. The workshop will also examine the role of NLR, GLR, and CRP in disease severity assessment and explore how factors such as age and comorbidities can influence biomarker interpretation.

🔗Sign up here: https://eu1.hubs.ly/H0yZ8l20

07/10/2026

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!
Join us October 7-10 and visit our partner DIAMEDIC at Booth #27 to discover the latest innovations in hematology and hemostasis, including the Yumizen H500 hematology analyzer and the Yumizen G405 hemostasis analyzer.

Don't miss our exclusive HORIBA workshops on October 9:
🔹 Coagulation Workshop: The Clinical Value and Biological Variability of D-Dimer Assays, Presented by Bruno Pougault, HORIBA ABX SAS
🔹 Hematology Workshop: Clinical Performance of Immature Leukocytes and Blasts from Extended Leukocyte Differential Counts and System Flags on HORIBA Yumizen H2500, Presented by Pascal Berthet, HORIBA ABX SAS

Whether you're a laboratory technician, laboratory manager, clinician, distributor, or interested in becoming a HORIBA distribution partner in Latin America, this is a great opportunity to connect with our team, explore our solutions, and discuss future collaborations.

We look forward to meeting you in Bolivia!

Congress registration: https://eu1.hubs.ly/H0yVLF40

06/10/2026

In this short video, Dr. Gulnaz Zhumagualieva, Head of the Laboratory at Sayram Central District Hospital, shares her experience after nearly six years of using the semi-automated hemostasis analyzer Yumizen G400 she introduced, and explains how evolving requirements are shaping future automation plans.
👉Discover the Yumizen hemostasis solutions here: https://eu1.hubs.ly/H0yS-DJ0

02/10/2026

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!
Join us October 7-10 and visit our partner DIAMEDIC at Booth #27 to discover the latest innovations in hematology and hemostasis, including the Yumizen H500 hematology analyzer and the Yumizen G405 hemostasis analyzer.

Don't miss our exclusive HORIBA workshops on October 9:
🔹 Coagulation Workshop: The Clinical Value and Biological Variability of D-Dimer Assays, Presented by Bruno Pougault, HORIBA ABX SAS
🔹 Hematology Workshop: Clinical Performance of Immature Leukocytes and Blasts from Extended Leukocyte Differential Counts and System Flags on HORIBA Yumizen H2500, Presented by Pascal Berthet, HORIBA ABX SAS

Whether you're a laboratory technician, laboratory manager, clinician, distributor, or interested in becoming a HORIBA distribution partner in Latin America, this is a great opportunity to connect with our team, explore our solutions, and discuss future collaborations.

We look forward to meeting you in Bolivia!

Congress registration: https://eu1.hubs.ly/H0yrv7S0

01/10/2026

When dengue NS1 antigen and antibody tests come back negative during the acute phase, clinicians face a diagnostic gap at the moment it matters most. This case report followed a 21-year-old patient through secondary dengue infection, from a negative NS1 result on day 3 through seroconversion on day 11. While standard serological markers missed the window, serial complete blood counts performed on the HORIBA Yumizen H500 hematology analyzer captured the immune response in real time.

Extended white blood cell differential parameters, including immature granulocytes, immature monocytes, atypical lymphocytes, and large immature cells, tracked the activation of both innate and adaptive immune responses as the disease progressed. Inflammatory indices calculated from the same CBC data (neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio) reflected clinical deterioration and recovery in parallel with the patient's course.

These parameters are repeatable, practical, and cost-effective. In resource-limited settings where advanced serological testing may not be readily available, they offer a way to monitor disease progression using equipment already present in the laboratory.

🔗Read the full case report: https://eu1.hubs.ly/H0yLy1g0

01/10/2026

Every story is unique and every journey matters. HORIBA joins the global effort to raise awareness of breast cancer. Throughout October, we highlight the importance of early detection and stand in support of all those affected by the disease. 🩷Take care of yourself. Get screened.